AYTU Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.34%

Insider Buying (Last 12 Months): $97,201.62

Insider Selling (Last 12 Months): $0.00

Aytu BioPharma Insider Trading History Chart

Aytu BioPharma Share Price & Price History

^$2.70

▲ +0.03 (1.12%)

As of 09/29/2023 01:00 AM ET

Days: 30 | 90 | 365

Elon Did It Again: This Could be Bigger than Tesla

From Legacy Research | Ad

Love him or hate him, it’s hard to deny Elon Musk is a genius.

After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)...

He’s getting ready to do it again with his new AI venture.

To get all the details, click here.

Aytu BioPharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/16/2023	Greg Pyszczymuka	Insider	Buy	12,000	$1.87	$22,440.00	21,935
6/14/2023	Joshua R Disbrow	CEO	Buy	14,000	$1.86	$26,040.00	71,591
12/19/2022	Greg Pyszczymuka	Insider	Buy	100,000	$0.24	$24,000.00	182,056
12/19/2022	Joshua R Disbrow	CEO	Buy	112,371	$0.22	$24,721.62	1,231,877
12/11/2020	Armistice Capital, Llc	Director	Buy	1,333,334	$6.00	$8,000,004.00

Biden's Digital Dollar Nightmare

From Goldco | Ad

On July 20th, 2023, the Federal Reserve launched FedNow, which could spark the fuse for a Digital Dollar. If a Digital Dollar happens, the government could: Monitor every transaction, keep track of your spending habits, and potentially control your individual choices… Which MAY steal your freedoms in one way or another. And if you don’t plan for this now... Your retirement savings could be at risk of being frozen, hacked, or deleted.

You’ll want to act fast... Because with Biden’s long history of voting against Americans... Who knows how much longer until Biden strikes again!

Get your hands on this FREE Wealth Protection Kit today and learn how you could shield your savings and investments before it’s too late!

Request Your FREE Kit Today!

SEC Filings (Institutional Ownership Changes) for Aytu BioPharma (NASDAQ:AYTU)

45.09% of Aytu BioPharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aytu BioPharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/16/2023	Stonepine Capital Management LLC	472,369	$0.76M	0.3%	N/A	12.497%
8/11/2023	Renaissance Technologies LLC	57,323	$92K	0.0%	+15.5%	1.516%
8/11/2023	Stonepine Capital Management LLC	472,369	$0.76M	0.3%	N/A	12.497%
5/16/2023	Geode Capital Management LLC	12,039	$27K	0.0%	-95.0%	0.318%
5/16/2023	Alyeska Investment Group L.P.	75,000	$0.17M	0.0%	-95.0%	1.984%
5/12/2023	Renaissance Technologies LLC	49,623	$0.11M	0.0%	-97.7%	1.313%
5/12/2023	BlackRock Inc.	24,059	$54K	0.0%	-95.0%	0.636%
5/12/2023	Prudential Financial Inc.	14,176	$32K	0.0%	-92.1%	0.375%
5/12/2023	Dimensional Fund Advisors LP	47,263	$0.11M	0.0%	N/A	1.250%
5/11/2023	Acadian Asset Management LLC	22,537	$50K	0.0%	-94.3%	0.596%
5/11/2023	Commonwealth Equity Services LLC	15,637	$35K	0.0%	-94.9%	0.414%
2/15/2023	Millennium Management LLC	1,189,958	$0.23M	0.0%	+190.3%	38.115%
2/13/2023	Renaissance Technologies LLC	2,140,782	$0.41M	0.0%	+22.5%	68.615%
2/7/2023	Commonwealth Equity Services LLC	309,558	$58K	0.0%	+47.7%	9.922%
11/15/2022	Vanguard Group Inc.	972,699	$0.18M	0.0%	-10.8%	1.558%
11/15/2022	Commonwealth Equity Services LLC	209,558	$38K	0.0%	+91.0%	0.336%
11/14/2022	Renaissance Technologies LLC	1,747,520	$0.32M	0.0%	+65.5%	2.799%
11/4/2022	Prudential Financial Inc.	145,550	$27K	0.0%	+257.2%	0.233%
8/16/2022	Prudential Financial Inc.	40,750	$28K	0.0%	N/A	0.104%
8/15/2022	Millennium Management LLC	174,797	$0.12M	0.0%	-34.3%	0.453%
8/13/2022	Renaissance Technologies LLC	1,055,782	$0.73M	0.0%	+37.9%	2.737%
5/13/2022	Renaissance Technologies LLC	765,469	$0.83M	0.0%	+15.1%	2.295%
5/13/2022	Vanguard Group Inc.	722,563	$0.78M	0.0%	-23.4%	2.166%
11/16/2021	Schonfeld Strategic Advisors LLC	20,200	$58K	0.0%	-22.8%	0.073%
11/12/2021	Renaissance Technologies LLC	660,604	$1.90M	0.0%	+38.4%	2.398%
11/10/2021	Creative Planning	13,000	$37K	0.0%	N/A	0.047%
11/9/2021	BlackRock Inc.	498,952	$1.44M	0.0%	+3.2%	1.811%
10/29/2021	Commonwealth Equity Services LLC	107,718	$0.31M	0.0%	+86.4%	0.391%
9/17/2021	Virtu Financial LLC	101,805	$0.51M	0.0%	N/A	0.404%
8/17/2021	Millennium Management LLC	440,415	$2.21M	0.0%	N/A	1.750%
8/16/2021	Squarepoint Ops LLC	34,487	$0.17M	0.0%	N/A	0.137%
8/16/2021	Pinz Capital Management LP	21,400	$0.11M	0.0%	+18.9%	0.085%
8/16/2021	State Street Corp	97,684	$0.49M	0.0%	-44.9%	0.388%
8/16/2021	Tibra Equities Europe Ltd	60,100	$0.30M	0.1%	N/A	0.239%
8/13/2021	Renaissance Technologies LLC	477,369	$2.39M	0.0%	+265.7%	1.897%
8/13/2021	Northern Trust Corp	47,061	$0.24M	0.0%	-77.9%	0.187%
8/13/2021	Geode Capital Management LLC	221,439	$1.11M	0.0%	-38.8%	0.880%
8/13/2021	Vanguard Group Inc.	983,387	$4.93M	0.0%	-5.6%	3.907%
8/12/2021	Ergoteles LLC	75,472	$0.38M	0.0%	N/A	0.300%
8/11/2021	Commonwealth Equity Services LLC	57,798	$0.29M	0.0%	+24.0%	0.230%
8/11/2021	Bank of New York Mellon Corp	15,919	$80K	0.0%	-66.0%	0.063%
8/11/2021	BlackRock Inc.	483,448	$2.42M	0.0%	-69.6%	1.921%
8/11/2021	Deutsche Bank AG	20,800	$0.10M	0.0%	+50.9%	0.083%
8/11/2021	Susquehanna Fundamental Investments LLC	54,819	$0.28M	0.0%	+33.7%	0.218%
8/10/2021	WINTON GROUP Ltd	57,229	$0.29M	0.0%	+22.7%	0.227%
5/24/2021	Principal Financial Group Inc.	42,551	$0.32M	0.0%	+8.2%	0.238%
5/21/2021	Citadel Advisors LLC	24,761	$0.19M	0.0%	-70.4%	0.138%
5/18/2021	Citadel Advisors LLC	24,761	$0.19M	0.0%	-70.4%	0.138%
5/18/2021	California State Teachers Retirement System	33,011	$0.25M	0.0%	+857.1%	0.185%
5/17/2021	Schonfeld Strategic Advisors LLC	27,100	$0.21M	0.0%	N/A	0.152%
5/17/2021	Armistice Capital LLC	1,342,378	$10.20M	0.2%	+0.7%	7.506%
5/17/2021	Pinz Capital Management LP	18,000	$0.14M	0.0%	N/A	0.101%
5/17/2021	Nuveen Asset Management LLC	276,148	$2.10M	0.0%	N/A	1.544%
5/17/2021	Goldman Sachs Group Inc.	77,958	$0.59M	0.0%	N/A	0.436%
5/14/2021	Occudo Quantitative Strategies LP	60,112	$0.46M	0.1%	N/A	0.336%
5/13/2021	Brandywine Global Investment Management LLC	13,131	$100K	0.0%	N/A	0.073%
5/13/2021	Renaissance Technologies LLC	130,521	$0.99M	0.0%	N/A	0.730%
5/13/2021	Bank of New York Mellon Corp	46,833	$0.36M	0.0%	+215.2%	0.262%
5/12/2021	Northern Trust Corp	213,140	$1.62M	0.0%	+335.4%	1.192%
5/12/2021	Geode Capital Management LLC	361,588	$2.75M	0.0%	+249.8%	2.022%
5/12/2021	JPMorgan Chase & Co.	55,385	$0.42M	0.0%	+634.8%	0.310%
5/10/2021	Hunter Associates Investment Management LLC	10,880	$83K	0.0%	N/A	0.061%
5/10/2021	Principal Financial Group Inc.	42,551	$0.32M	0.0%	+8.2%	0.238%
5/7/2021	BlackRock Inc.	1,588,371	$12.07M	0.0%	+417.7%	8.882%
5/7/2021	American International Group Inc.	12,755	$97K	0.0%	+804.6%	0.071%
5/6/2021	Rhumbline Advisers	13,836	$0.11M	0.0%	N/A	0.077%
5/6/2021	Sigma Planning Corp	10,722	$81K	0.0%	N/A	0.060%
5/4/2021	Commonwealth Equity Services LLC	46,605	$0.35M	0.0%	+88.7%	0.261%
5/3/2021	The Manufacturers Life Insurance Company	13,682	$0.10M	0.0%	N/A	0.077%
2/23/2021	Principal Financial Group Inc.	39,316	$0.24M	0.0%	N/A	0.220%
2/19/2021	JPMorgan Chase & Co.	7,537	$45K	0.0%	-78.5%	0.058%
2/16/2021	Squarepoint Ops LLC	34,862	$0.21M	0.0%	N/A	0.267%
2/16/2021	Armistice Capital LLC	1,333,334	$7.97M	0.3%	N/A	7.456%
2/16/2021	Charles Schwab Investment Management Inc.	11,007	$66K	0.0%	-90.0%	0.084%
2/12/2021	Stonepine Capital Management LLC	1,398,776	$8.37M	6.4%	N/A	10.694%
2/11/2021	Northern Trust Corp	48,951	$0.29M	0.0%	-89.5%	0.374%
2/9/2021	Wells Fargo & Company MN	18,219	$0.11M	0.0%	-87.2%	0.139%
2/9/2021	Bank of New York Mellon Corp	14,857	$89K	0.0%	-81.3%	0.114%
2/8/2021	New York State Common Retirement Fund	6,630	$40K	0.0%	-90.0%	0.051%
2/5/2021	BlackRock Inc.	306,813	$1.84M	0.0%	-89.7%	2.346%
2/4/2021	Searle & CO.	14,000	$84K	0.0%	-81.3%	0.107%
11/17/2020	Jane Street Group LLC	56,903	$68K	0.0%	-80.5%	0.044%
11/12/2020	JPMorgan Chase & Co.	34,976	$42K	0.0%	+66.3%	0.028%
11/10/2020	State Street Corp	289,910	$0.35M	0.0%	+26.4%	0.230%
11/9/2020	Verdence Capital Advisors LLC	56,542	$67K	0.0%	-24.1%	0.045%
11/9/2020	LPL Financial LLC	24,100	$29K	0.0%	N/A	0.019%
11/6/2020	BlackRock Inc.	2,975,685	$3.54M	0.0%	+168.8%	2.365%
10/19/2020	Beech Hill Advisors Inc.	30,000	$36K	0.0%	+200.0%	0.024%
8/25/2020	Nuveen Asset Management LLC	209,955	$0.30M	0.0%	N/A	0.174%
8/20/2020	Charles Schwab Investment Management Inc.	49,328	$71K	0.0%	N/A	0.041%
8/17/2020	Jane Street Group LLC	291,129	$0.41M	0.0%	N/A	0.241%
8/14/2020	Bank of America Corp DE	257,363	$0.37M	0.0%	+222.0%	0.213%
8/14/2020	Advisor Group Holdings Inc.	31,872	$46K	0.0%	+145.1%	0.026%
8/12/2020	Algert Global LLC	37,690	$54K	0.0%	N/A	0.031%
8/12/2020	Goldman Sachs Group Inc.	40,163	$57K	0.0%	-33.8%	0.033%
8/12/2020	Bank of New York Mellon Corp	78,112	$0.11M	0.0%	N/A	0.065%
8/12/2020	Commonwealth Equity Services LLC	87,021	$0.12M	0.0%	+220.2%	0.072%
8/11/2020	Global Strategic Investment Solutions LLC	22,000	$31K	0.0%	N/A	0.018%
8/10/2020	HighTower Advisors LLC	24,849	$35K	0.0%	+52.0%	0.021%
8/7/2020	Virtu Financial LLC	96,976	$0.14M	0.0%	N/A	0.080%

Data available starting January 2016

Aytu Biopharma, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates into two segments Rx segment and Consumer Health segment. The Rx segment consisting of prescription pharmaceutical products sold through third party wholesalers. The Consumer Health segment, which consists of various consumer health products sell directly to consumers. It also offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. In addition, the company provides Karbinal ER, for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.

Today's Range

Now: $2.70

$2.46

$2.94

50 Day Range

MA: $1.74

$1.53

$2.70

52 Week Range

Now: $2.70

$1.38

$4.88

Volume

635,145 shs

Average Volume

339,895 shs

Market Capitalization

$10.21 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Aytu BioPharma?: Aytu BioPharma's top insider investors include:
Joshua R Disbrow (CEO)
Greg Pyszczymuka (Insider)
Learn More about top insider investors at Aytu BioPharma.